FOSFOMYCIN IN CHEMOTHERAPY OF EXPERIMENTAL PLEUROPNEUMONIAKRUGER C; MARRE R.1981; DRUGS EXP. CLIN. RES.; ISSN 0378-6501; CHE; DA. 1981; VOL. 7; NO 4; PP. 565-569; BIBL. 11 REF.Article

ANTIMICROBIAL AGENTS IN RATS. I: SERUM LEVELS OF PARENTERAL CEPHALOSPORINSMARRE R; FREIESLEBEN H.1979; ARZNEIMITTEL-FORSCH.; DEU; DA. 1979; VOL. 29; NO 6; PP. 932-934; ABS. GER; BIBL. 39 REF.Article

THERAPIEERGEBNISSE MIT FOSFOMYCIN, CEFOXITIN UND CEFOTAXIM AN EXPERIMENTELLER E. COLI-PLEUROPNEUMONIE = TRAITEMENT PAR LA FOSFOMYCINE, LA CEFOXITINE ET LA CEFOTAXIME D'UNE PLEUROPNEUMONIE EXPERIMENTALE A E.C.KRUEGER C; MARRE R; HENKEL W et al.1981; IMMUN. INFEKT.; ISSN 0340-1162; DEU; DA. 1981; VOL. 9; NO 1; PP. 29-32; ABS. ENG; BIBL. 15 REF.Article

CHARACTERIZATION OF THE BETA-LACTAMASE OF SIX SPECIES OF LEGIONELLAMARRE R; MEDEIROS AA; PASCULLE AW et al.1982; J. BACTERIOL.; ISSN 0021-9193; USA; DA. 1982; VOL. 151; NO 1; PP. 216-221; BIBL. 20 REF.Article

INFLUENCE OF R-PLASMID MEDIATED BETA -LACTAMASE PRODUCTION ON THE THERAPEUTIC EFFICACY OF CEFOXITIN AND CEFAMANDOLE IN EXPERIMENTAL CHEMOTHERAPYMARRE R; SCHULZ E; FREIESLEBEN H et al.1980; J. ANTIMICROB. CHEMOTHER.; ISSN 0305-7453; GBR; DA. 1980; VOL. 6; NO 5; PP. 633-638; BIBL. 7 REF.Article

FOSFOMYCIN: TIEREXPERIMENTELLE UNTERSUCHUNG ZUR NEPHROTOXIZITAET, PHARMAKOKINETIK UND THERAPEUTISCHEN EFFEKTIVITAET = FOSFOMYCINE: ETUDE EXPERIMENTALE CHEZ L'ANIMAL DE LA NEPHROTOXICITE PHARMACOCINETIQUE ET EFFICACITE THERAPEUTIQUELEPERE A; MARRE R; SACK K et al.1980; IMMUN. INFEKT.; ISSN 0340-1162; DEU; DA. 1980; VOL. 8; NO 3; PP. 101-107; ABS. ENG; BIBL. 26 REF.Article

Cloning and expression of Staphylococcus saprophyticus urease gene sequences in Staphylococcus carnosus and contribution of the enzyme to virulenceGATERMANN, S; MARRE, R.Infection and immunity. 1989, Vol 57, Num 10, pp 2998-3002, issn 0019-9567Article

In vitro activity of mecillinam and amoxicillin/clanulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal β-lactamasesMARRE, R; SCHULZ, E.Arzneimittel-Forschung. 1988, Vol 38, Num 7, pp 863-865, issn 0004-4172Article

Role of S- and common-type I-fimbriae of Escherichia coli in experimental upper and lower urinary tract infectionMARRE, R; HACKER, J.Microbial pathogenesis. 1987, Vol 2, Num 3, pp 223-226, issn 0882-4010Article

Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known β-lactamasesGATERMANN, S; MARRE, R.Infection. 1991, Vol 19, Num 2, pp 106-109, issn 0300-8126, 4 p.Article

CEFTAZIDIME, CEFTIZOXIME, CEFOTAXIME AND HR 221 IN EXPERIMENTAL CHRONIC ESCHERICHIA COLI PYELONEPHRITIS IN RATSMARRE R; HERHAHN D; SCHULZ E et al.1983; INFECTION; ISSN 0300-8126; DEU; DA. 1983; VOL. 11; SUPPL. 1; PP. 54-56; ABS. GER; BIBL. 16 REF.Article

NETILMICIN UND TOBRAMYCIN: VERGLEICHENDE TIEREXPERIMENTELLE UNTERSUCHUNGEN ZUR PHARMAKOKINETIK, NIERENVERTRAEGLICHKEIT UND THERAPEUTISCHEN EFFEKTIVITAET = LA NETILMICINE ET LA TOBRAMYCINE: RECHERCHES EXPERIMENTALES COMPAREES CHEZ L'ANIMAL SUR LA PHARMACOCINETIQUE, LA TOLERANCE RENALE ET L'EFFICACITE THERAPEUTIQUEMARRE R; ABRAHAM M; FREIESLEBEN H et al.1979; ARZNEIMITTEL-FORSCH.; DEU; DA. 1979; VOL. 29; NO 6; PP. 940-945; ABS. ENG; BIBL. 46 REF.Article

ANTIMICROBIAL AGENTS IN RATS. II: SERUM LEVELS OF ORAL CEPHALOSPORINSMARRE R; FREIESLEBEN H; BECK H et al.1979; ARZNEIMITTEL-FORSCH.; DEU; DA. 1979; VOL. 29; NO 7; PP. 990-992; ABS. GERArticle

TIEREXPERIMENTELLE STUDIEN ZUR NIERENVERTRAEGLICHKEIT, PHARMAKOKINETIK UND THERAPEUTISCHEN EFFEKTIVITAET VON DIBEKACIN = ETUDE EXPERIMENTALE SUR L'ANIMAL DE LA TOLERANCE RENALE DE LA PHARMACOCINETIQUE ET DE L'EFFICACITE THERAPEUTIQUE DE LA DIBEKACINEBOPP S; MARRE R; SCHULZ E et al.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 3; PP. 473-477; ABS. ENG; BIBL. 32 REF.Article

TIEREXPERIMENTELLE UNTERSUCHUNGEN ZUR NEPHROTOXIZITAET VON 7 AMINOGLYKOSIDEN BEI LANGZEITBEHANDLUNG = RECHERCHES EXPERIMENTALES CHEZ L'ANIMAL SUR LA NEPHROTOXICITE DE 7 AMINOGLUCOSIDES LORS DU TRAITEMENT A LONG TERMEBECK H; ZUELLICH B; MARRE R et al.1979; ARZNEIMITTEL-FORSCH.; DEU; DA. 1979; VOL. 29; NO 6; PP. 935-939; ABS. ENG; BIBL. 15 REF.Article

Legionella pneumophila invasion of MRC-5 cells induces tyrosine protein phosphorylationSUSA, M; MARRE, R.Infection and immunity. 1999, Vol 67, Num 9, pp 4490-4498, issn 0019-9567Article

AGE-DEPENDENT NEPHROTOXICITY AND THE PHARMACOKINETICS OF GENTAMICIN IN RATSMARRE R; TARARA N; LOUTON T et al.1980; EUROP. J. PEDIATR.; DEU; DA. 1980; VOL. 133; NO 1; PP. 25-29; BIBL. 18 REF.Article

INVESTIGATIONS ON THE EFFECTIVENESS OF CEFAZEDONE IN EXPERIMENTAL E.COLI PYCLONEPHRITISSACK K; MARRE R; FREIESLEBEN H et al.1979; ARZNEIMITTEL-FORSCH.; DEU; DA. 1979; VOL. 29; NO 2A; PP. 414-416; ABS. GER; BIBL. 10 REF.Article

TIEREXPERIMENTELLE UNTERSUCHUNGEN UEBER DIE ANTIBAKTERIELLE AKTIVITAET VON 10 CEPHALOSPORINEN = ETUDES EXPERIMENTALES SUR ANIMAL DE L'ACTIVITE ANTIBACTERIENNE DE 10 CEPHALOSPORINESMARRE R; ZUELLICH B; BECK H et al.1978; ZBL. BAKTERIOL. PARASITENKDE INFEKT.-KRANKH. HYG., 1,A; DEU; DA. 1978; VOL. 240; NO 4; PP. 529-537; ABS. ENG; BIBL. 13 REF.Article

CEFUROXIM: EXPERIMENTELLE THERAPIESTUDIEN = CEFUROXIM: ETUDES EXPERIMENTALES THERAPEUTIQUESSCHULZ E; FREISLEBEN H; SACK K et al.1978; THERAPIEWOCHE; DEU; DA. 1978; VOL. 28; NO 34; PP. 6099-6103; ABS. ENG; BIBL. 22 REF.Article

ANTIBAKTERIELLE IN-VITRO-WIRKSAMKEIT VON PIPEMIDSAEURE UND NALIDIXINSAEURE. VERGLEICHENDE UNTERSUCHUNGEN = ACTIVITE ANTIBACTERIENNE IN VITRO DE L'ACIDE PIPEMIDIQUE ET DE L'ACIDE NALIDIXINIQUE. ETUDE COMPARATIVEPETERS G; FREIESLEBEN H; MARRE R et al.1979; DTSCHE MED. WSCHR.; DEU; DA. 1979; VOL. 104; NO 26; PP. 946-948; ABS. ENG; BIBL. 6 REF.Article

Prevalence of antibiotic resistance in Escherichia coli : overview of geographical, temporal, and methodological variationsERB, A; STÜRMER, T; MARRE, R et al.European journal of clinical microbiology & infectious diseases (Print). 2007, Vol 26, Num 2, pp 83-90, issn 0934-9723, 8 p.Article

Properties of Escherichia coli strains of serotype O6BLUM, G; MARRE, R; HACKER, J et al.Infection. 1995, Vol 23, Num 4, pp 234-236, issn 0300-8126Article

Page / 5